PIBAX
Price
$17.46
Change
+$0.03 (+0.17%)
Updated
May 22 closing price
Net Assets
974.96M
RLBCX
Price
$34.67
Change
+$0.03 (+0.09%)
Updated
May 22 closing price
Net Assets
237.69B
Interact to see
Advertisement

PIBAX vs RLBCX

Header iconPIBAX vs RLBCX Comparison
Open Charts PIBAX vs RLBCXBanner chart's image
PGIM Balanced A
Price$17.46
Change+$0.03 (+0.17%)
VolumeN/A
Net Assets974.96M
American Funds American Balanced R3
Price$34.67
Change+$0.03 (+0.09%)
VolumeN/A
Net Assets237.69B
PIBAX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PIBAX vs. RLBCX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PIBAX is a StrongBuy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 238B vs. PIBAX (975M). PIBAX pays higher dividends than RLBCX: PIBAX (2.24) vs RLBCX (1.70). PIBAX was incepted earlier than RLBCX: PIBAX (29 years) vs RLBCX (23 years). PIBAX (1.12) is less costly to investors than RLBCX (0.89). PIBAX is a more actively managed with annual turnover of: 107.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than PIBAX: RLBCX (250) vs PIBAX (1000). RLBCX annual gain was more profitable for investors over the last year : 4.44 vs. PIBAX (1.28). RLBCX return over 5 years is better than : 36.27 vs. PIBAX (27.99).
PIBAXRLBCXPIBAX / RLBCX
Total Expense Ratio1.000.89112%
Annual Report Gross Expense Ratio1.120.89126%
Fund Existence29 years23 years-
Gain YTD0.9871.88152%
Front Load3%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets975M238B0%
Annual Yield % from dividends2.241.70132%
Returns for 1 year1.284.4429%
Returns for 3 years19.8321.6891%
Returns for 5 years27.9936.2777%
Returns for 10 years27.4249.7255%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ULBI5.530.14
+2.60%
Ultralife Corp
RUN10.66N/A
N/A
Sunrun
AMCR9.05N/A
N/A
Amcor plc
UWMC3.97N/A
N/A
UWM Holdings Corp
LYRA0.09N/A
-1.70%
Lyra Therapeutics